Loading…

Development of Spin-Labeled Probes for Adenosine Receptors

Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2005-03, Vol.48 (6), p.2108-2114
Main Authors: Ilaš, Janez, Pečar, Slavko, Hockemeyer, Jörg, Euler, Harald, Kirfel, Armin, Müller, Christa E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23
cites cdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23
container_end_page 2114
container_issue 6
container_start_page 2108
container_title Journal of medicinal chemistry
container_volume 48
creator Ilaš, Janez
Pečar, Slavko
Hockemeyer, Jörg
Euler, Harald
Kirfel, Armin
Müller, Christa E
description Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, >200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.
doi_str_mv 10.1021/jm049513x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67528505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67528505</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</originalsourceid><addsrcrecordid>eNpt0EtLw0AUBeBBFFsfC_-AZKPgIjrvSdwV31LR2orLYTq9A6lJJs6kov_eSEu7cXUX9-NwOAgdEXxOMCUX8wrzXBD2vYX6RFCc8gzzbdTHmNKUSsp6aC_GOcaYEcp2UY8IpQgXrI8ur-ELSt9UULeJd8m4Kep0aKZQwix5CX4KMXE-JIMZ1D4WNSSvYKFpfYgHaMeZMsLh6u6jt9ubydV9Ony-e7gaDFPDMtKmucmlM5myMsvxLLdcEjflXFBFGaOKAHWUmtw6K5USmGeW0M6Bw1wyZijbR6fL3Cb4zwXEVldFtFCWpga_iFoqQTOBRQfPltAGH2MAp5tQVCb8aIL131B6PVRnj1ehi2kFs41cLdOBkxUw0ZrSBVPbIm6clEJw8ufSpStiC9_rvwkfXTGmhJ68jPXkKX8c3Y9y_b7JNTbquV-Eutvun4K_1Z-JMQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67528505</pqid></control><display><type>article</type><title>Development of Spin-Labeled Probes for Adenosine Receptors</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Ilaš, Janez ; Pečar, Slavko ; Hockemeyer, Jörg ; Euler, Harald ; Kirfel, Armin ; Müller, Christa E</creator><creatorcontrib>Ilaš, Janez ; Pečar, Slavko ; Hockemeyer, Jörg ; Euler, Harald ; Kirfel, Armin ; Müller, Christa E</creatorcontrib><description>Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, &gt;200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm049513x</identifier><identifier>PMID: 15771453</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Adenosine A1 Receptor Antagonists ; Adenosine A2 Receptor Antagonists ; Animals ; Binding, Competitive ; Biological and medical sciences ; Brain - drug effects ; Brain - metabolism ; Cell Line ; Cricetinae ; Cricetulus ; Crystallography, X-Ray ; Cyclic N-Oxides - chemical synthesis ; Cyclic N-Oxides - chemistry ; Cyclic N-Oxides - pharmacology ; Cyclopentanes - chemical synthesis ; Cyclopentanes - chemistry ; Cyclopentanes - pharmacology ; Humans ; In Vitro Techniques ; Ligands ; Medical sciences ; Molecular Structure ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Purinergic P1 Receptor Antagonists ; Radioligand Assay ; Rats ; Receptor, Adenosine A1 - metabolism ; Receptor, Adenosine A2B - metabolism ; Receptors, Purinergic P1 - metabolism ; Spin Labels - chemical synthesis ; Structure-Activity Relationship ; Xanthines - chemical synthesis ; Xanthines - chemistry ; Xanthines - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2108-2114</ispartof><rights>Copyright © 2005 American Chemical Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</citedby><cites>FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16655413$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15771453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ilaš, Janez</creatorcontrib><creatorcontrib>Pečar, Slavko</creatorcontrib><creatorcontrib>Hockemeyer, Jörg</creatorcontrib><creatorcontrib>Euler, Harald</creatorcontrib><creatorcontrib>Kirfel, Armin</creatorcontrib><creatorcontrib>Müller, Christa E</creatorcontrib><title>Development of Spin-Labeled Probes for Adenosine Receptors</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, &gt;200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.</description><subject>Adenosine A1 Receptor Antagonists</subject><subject>Adenosine A2 Receptor Antagonists</subject><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Cell Line</subject><subject>Cricetinae</subject><subject>Cricetulus</subject><subject>Crystallography, X-Ray</subject><subject>Cyclic N-Oxides - chemical synthesis</subject><subject>Cyclic N-Oxides - chemistry</subject><subject>Cyclic N-Oxides - pharmacology</subject><subject>Cyclopentanes - chemical synthesis</subject><subject>Cyclopentanes - chemistry</subject><subject>Cyclopentanes - pharmacology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Purinergic P1 Receptor Antagonists</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Receptor, Adenosine A1 - metabolism</subject><subject>Receptor, Adenosine A2B - metabolism</subject><subject>Receptors, Purinergic P1 - metabolism</subject><subject>Spin Labels - chemical synthesis</subject><subject>Structure-Activity Relationship</subject><subject>Xanthines - chemical synthesis</subject><subject>Xanthines - chemistry</subject><subject>Xanthines - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpt0EtLw0AUBeBBFFsfC_-AZKPgIjrvSdwV31LR2orLYTq9A6lJJs6kov_eSEu7cXUX9-NwOAgdEXxOMCUX8wrzXBD2vYX6RFCc8gzzbdTHmNKUSsp6aC_GOcaYEcp2UY8IpQgXrI8ur-ELSt9UULeJd8m4Kep0aKZQwix5CX4KMXE-JIMZ1D4WNSSvYKFpfYgHaMeZMsLh6u6jt9ubydV9Ony-e7gaDFPDMtKmucmlM5myMsvxLLdcEjflXFBFGaOKAHWUmtw6K5USmGeW0M6Bw1wyZijbR6fL3Cb4zwXEVldFtFCWpga_iFoqQTOBRQfPltAGH2MAp5tQVCb8aIL131B6PVRnj1ehi2kFs41cLdOBkxUw0ZrSBVPbIm6clEJw8ufSpStiC9_rvwkfXTGmhJ68jPXkKX8c3Y9y_b7JNTbquV-Eutvun4K_1Z-JMQ</recordid><startdate>20050324</startdate><enddate>20050324</enddate><creator>Ilaš, Janez</creator><creator>Pečar, Slavko</creator><creator>Hockemeyer, Jörg</creator><creator>Euler, Harald</creator><creator>Kirfel, Armin</creator><creator>Müller, Christa E</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050324</creationdate><title>Development of Spin-Labeled Probes for Adenosine Receptors</title><author>Ilaš, Janez ; Pečar, Slavko ; Hockemeyer, Jörg ; Euler, Harald ; Kirfel, Armin ; Müller, Christa E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenosine A1 Receptor Antagonists</topic><topic>Adenosine A2 Receptor Antagonists</topic><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Cell Line</topic><topic>Cricetinae</topic><topic>Cricetulus</topic><topic>Crystallography, X-Ray</topic><topic>Cyclic N-Oxides - chemical synthesis</topic><topic>Cyclic N-Oxides - chemistry</topic><topic>Cyclic N-Oxides - pharmacology</topic><topic>Cyclopentanes - chemical synthesis</topic><topic>Cyclopentanes - chemistry</topic><topic>Cyclopentanes - pharmacology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Purinergic P1 Receptor Antagonists</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Receptor, Adenosine A1 - metabolism</topic><topic>Receptor, Adenosine A2B - metabolism</topic><topic>Receptors, Purinergic P1 - metabolism</topic><topic>Spin Labels - chemical synthesis</topic><topic>Structure-Activity Relationship</topic><topic>Xanthines - chemical synthesis</topic><topic>Xanthines - chemistry</topic><topic>Xanthines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ilaš, Janez</creatorcontrib><creatorcontrib>Pečar, Slavko</creatorcontrib><creatorcontrib>Hockemeyer, Jörg</creatorcontrib><creatorcontrib>Euler, Harald</creatorcontrib><creatorcontrib>Kirfel, Armin</creatorcontrib><creatorcontrib>Müller, Christa E</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ilaš, Janez</au><au>Pečar, Slavko</au><au>Hockemeyer, Jörg</au><au>Euler, Harald</au><au>Kirfel, Armin</au><au>Müller, Christa E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Spin-Labeled Probes for Adenosine Receptors</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2005-03-24</date><risdate>2005</risdate><volume>48</volume><issue>6</issue><spage>2108</spage><epage>2114</epage><pages>2108-2114</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, &gt;200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>15771453</pmid><doi>10.1021/jm049513x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2108-2114
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_67528505
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Adenosine A1 Receptor Antagonists
Adenosine A2 Receptor Antagonists
Animals
Binding, Competitive
Biological and medical sciences
Brain - drug effects
Brain - metabolism
Cell Line
Cricetinae
Cricetulus
Crystallography, X-Ray
Cyclic N-Oxides - chemical synthesis
Cyclic N-Oxides - chemistry
Cyclic N-Oxides - pharmacology
Cyclopentanes - chemical synthesis
Cyclopentanes - chemistry
Cyclopentanes - pharmacology
Humans
In Vitro Techniques
Ligands
Medical sciences
Molecular Structure
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Purinergic P1 Receptor Antagonists
Radioligand Assay
Rats
Receptor, Adenosine A1 - metabolism
Receptor, Adenosine A2B - metabolism
Receptors, Purinergic P1 - metabolism
Spin Labels - chemical synthesis
Structure-Activity Relationship
Xanthines - chemical synthesis
Xanthines - chemistry
Xanthines - pharmacology
title Development of Spin-Labeled Probes for Adenosine Receptors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Spin-Labeled%20Probes%20for%20Adenosine%20Receptors&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ila%C5%A1,%20Janez&rft.date=2005-03-24&rft.volume=48&rft.issue=6&rft.spage=2108&rft.epage=2114&rft.pages=2108-2114&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm049513x&rft_dat=%3Cproquest_cross%3E67528505%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67528505&rft_id=info:pmid/15771453&rfr_iscdi=true